These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 31775647)
1. Dealing with indeterminate outcomes in antimalarial drug efficacy trials: a comparison between complete case analysis, multiple imputation and inverse probability weighting. Dahal P; Stepniewska K; Guerin PJ; D'Alessandro U; Price RN; Simpson JA BMC Med Res Methodol; 2019 Nov; 19(1):215. PubMed ID: 31775647 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis. WorldWide Antimalarial Resistance Network Methodology Study Group Malar J; 2019 Jul; 18(1):225. PubMed ID: 31277713 [TBL] [Abstract][Full Text] [Related]
4. Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children. Ashley EA; Pinoges L; Turyakira E; Dorsey G; Checchi F; Bukirwa H; van den Broek I; Zongo I; Urruta PP; van Herp M; Balkan S; Taylor WR; Olliaro P; Guthmann JP Malar J; 2008 Aug; 7():154. PubMed ID: 18691429 [TBL] [Abstract][Full Text] [Related]
5. Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study. Dahal P; Guerin PJ; Price RN; Simpson JA; Stepniewska K BMC Med Res Methodol; 2019 May; 19(1):107. PubMed ID: 31101088 [TBL] [Abstract][Full Text] [Related]
6. Variation in Calculating and Reporting Antimalarial Efficacy against Plasmodium falciparum in Sub-Saharan Africa: A Systematic Review of Published Reports. Plucinski MM; Hastings IM; Moriarty LF; Venkatesan M; Felger I; Halsey ES Am J Trop Med Hyg; 2021 Mar; 104(5):1820-1829. PubMed ID: 33724925 [TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962 [TBL] [Abstract][Full Text] [Related]
8. Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis. WorldWide Antimalarial Resistance Network Methodology Study Group Malar J; 2022 Mar; 21(1):106. PubMed ID: 35331243 [TBL] [Abstract][Full Text] [Related]
10. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. Stepniewska K; White NJ Malar J; 2006 Dec; 5():127. PubMed ID: 17187673 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of multiple imputation approaches for handling missing covariate information in a case-cohort study with a binary outcome. Middleton M; Nguyen C; Moreno-Betancur M; Carlin JB; Lee KJ BMC Med Res Methodol; 2022 Apr; 22(1):87. PubMed ID: 35369860 [TBL] [Abstract][Full Text] [Related]
12. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM; Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078 [TBL] [Abstract][Full Text] [Related]
13. Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria. Isba R; Zani B; Gathu M; Sinclair D Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD011547. PubMed ID: 25702785 [TBL] [Abstract][Full Text] [Related]
16. Azithromycin for treating uncomplicated malaria. van Eijk AM; Terlouw DJ Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286 [TBL] [Abstract][Full Text] [Related]
17. AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial. Koita OA; Sangaré L; Miller HD; Sissako A; Coulibaly M; Thompson TA; Fongoro S; Diarra Y; Ba M; Maiga A; Diallo B; Mushatt DM; Mather FJ; Shaffer JG; Anwar AH; Krogstad DJ Lancet Infect Dis; 2017 Dec; 17(12):1266-1275. PubMed ID: 28916443 [TBL] [Abstract][Full Text] [Related]
18. Missing Data in Marginal Structural Models: A Plasmode Simulation Study Comparing Multiple Imputation and Inverse Probability Weighting. Liu SH; Chrysanthopoulou SA; Chang Q; Hunnicutt JN; Lapane KL Med Care; 2019 Mar; 57(3):237-243. PubMed ID: 30664611 [TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border. Saito M; Carrara VI; Gilder ME; Min AM; Tun NW; Pimanpanarak M; Viladpai-Nguen J; Paw MK; Haohankhunnatham W; Konghahong K; Phyo AP; Chu C; Turner C; Lee SJ; Duanguppama J; Imwong M; Bancone G; Proux S; Singhasivanon P; White NJ; Nosten F; McGready R BMC Med; 2021 Jun; 19(1):132. PubMed ID: 34107963 [TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]